The impact of renin-angiotensin-aldosterone system blockade on heart failure outcomes and mortality in patients identified to have aortic regurgitation: A large population cohort study

Journal of the American College of Cardiology

Volumn 58, Issue 20, 2011, Pages 2084-2091

  Elder, Douglas H J ^a   Wei, Li ^a   Szwejkowski, Benjamin R ^a   Libianto, Renata ^b   Nadir, Adnan ^a   Pauriah, Maheshwar ^a   Rekhraj, Sushma ^a   Lim, Tiong K ^a   George, Jacob ^a   Doney, Alex ^a   Pringle, Stuart D ^a   Choy, Anna Maria ^a   Struthers, Allan D ^a   Lang, Chim C ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

angiotensin receptor blockers; angiotensin converting enzyme inhibitors; aortic regurgitation

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; AORTA VALVE REGURGITATION; ARTICLE; CARDIOVASCULAR RISK; CAUSE OF DEATH; COHORT ANALYSIS; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART VALVE REPLACEMENT; HOSPITALIZATION; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; POPULATION RESEARCH; PRESCRIPTION; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RETROSPECTIVE STUDY; RISK REDUCTION; SEX DIFFERENCE; UNITED KINGDOM;

AGED; AGED, 80 AND OVER; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; AORTIC VALVE INSUFFICIENCY; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SCOTLAND;

EID: 80155188416     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2011.07.043     Document Type: Article

References (34)

1. N.E. Lebowitz, J.N. Bella, and M.J. Roman Prevalence and correlates of aortic regurgitation in American Indians: the Strong Heart Study J Am Coll Cardiol 36 2000 461 467
2. W.A. Zoghbi, M. Enriquez-Sarano, and E. Foster Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography J Am Soc Echocardiogr 16 2003 777 802 (Pubitemid 37391035)
3. J. Ross Jr Adaptations of the left ventricle to chronic volume overload Circ Res 35 Suppl II 1974 64 70
4. M.P. Tornos, M. Olona, and G. Permanyer-Miralda Clinical outcome of severe asymptomatic chronic aortic regurgitation: a long-term prospective follow-up study Am Heart J 130 1995 333 339
5. R.O. Bonow, E. Lakatos, B.J. Maron, and S.E. Epstein Serial long-term assessment of the natural history of asymptomatic patients with chronic aortic regurgitation and normal left ventricular systolic function Circulation 84 1991 1625 1635
6. B.A. Carabello Aortic regurgitation. A lesion with similarities to both aortic stenosis and mitral regurgitation Circulation 82 1990 1051 1053 (Pubitemid 20316760)
7. W. Grossman, D. Jones, and L.P. McLaurin Wall stress and patterns of hypertrophy in the human left ventricle J Clin Invest 56 1975 56 64
8. T. Wisenbaugh, J.F. Spann, and B.A. Carabello Differences in myocardial performance and load between patients with similar amounts of chronic aortic versus chronic mitral regurgitation J Am Coll Cardiol 3 1984 916 923 (Pubitemid 14171206)
9. B. Greenberg, B. Massie, and J.D. Bristow Long-term vasodilator therapy of chronic aortic insufficiency A randomized double-blinded, placebo-controlled clinical trial Circulation 78 1988 92 103
10. R. Scognamiglio, G. Fasoli, A. Ponchia, and S. Dalla-Volta Long-term nifedipine unloading therapy in asymptomatic patients with chronic severe aortic regurgitation J Am Coll Cardiol 16 1990 424 429 (Pubitemid 20245863)
11. L. Sondergaard, J. Aldershvile, P. Hildebrandt, H. Kelbaek, F. Stahlberg, and C. Thomsen Vasodilatation with felodipine in chronic asymptomatic aortic regurgitation Am Heart J 139 2000 667 674 (Pubitemid 30207794)
12. B.H. Greenberg, H. DeMots, E. Murphy, and S.H. Rahimtoola Mechanism for improved cardiac performance with arteriolar dilators in aortic insufficiency Circulation 63 1981 263 268 (Pubitemid 11168741)
13. B.H. Greenberg, H. DeMots, E. Murphy, and S. Rahimtoola Beneficial effects of hydralazine on rest and exercise hemodynamics in patients with chronic severe aortic insufficiency Circulation 62 1980 49 55 (Pubitemid 10083096)
14. P. Fioretti, B. Benussi, S. Scardi, S. Klugmann, R.W. Brower, and F. Camerini Afterload reduction with nifedipine in aortic insufficiency Am J Cardiol 49 1982 1728 1732 (Pubitemid 12003486)
15. M. Lin, H.T. Chiang, and S.L. Lin Vasodilator therapy in chronic asymptomatic aortic regurgitation: enalapril versus hydralazine therapy J Am Coll Cardiol 24 1994 1046 1053 (Pubitemid 24306417)
16. D. Alehan, and S. Ozkutlu Beneficial effects of 1-year captopril therapy in children with chronic aortic regurgitation who have no symptoms Am Heart J 135 1998 598 603 (Pubitemid 28164893)
17. T. Wisenbaugh, V. Sinovich, A. Dullabh, and P. Sareli Six month pilot study of captopril for mildly symptomatic, severe isolated mitral and isolated aortic regurgitation J Heart Valve Dis 3 1994 197 204 (Pubitemid 24096143)
18. H.R. Schon, R. Dorn, P. Barthel, and A. Schomig Effects of 12 months quinapril therapy in asymptomatic patients with chronic aortic regurgitation J Heart Valve Dis 3 1994 500 509 (Pubitemid 24305457)
19. A. Evangelista, P. Tornos, A. Sambola, G. Permanyer-Miralda, and J. Soler-Soler Long-term vasodilator therapy in patients with severe aortic regurgitation N Engl J Med 353 2005 1342 1349 (Pubitemid 41362702)
20. R.O. Bonow, B.A. Carabello, and K. Chatterjee ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) J Am Coll Cardiol 48 2006 e1 e148 (Pubitemid 44109952)
21. E. Plante, M. Gaudreau, and D. Lachance Angiotensin-converting enzyme inhibitor captopril prevents volume overload cardiomyopathy in experimental chronic aortic valve regurgitation Canadian journal of physiology and pharmacology 82 2004 191 199 (Pubitemid 38621692)
22. E. Plante, D. Lachance, and J. Beaudoin Comparative study of vasodilators in an animal model of chronic volume overload caused by severe aortic regurgitation Circulation Heart Failure 2 2009 25 32
23. M.A. Nadir, L. Wei, and D.H.J. Elder Impact of renin-angiotensin system blockade therapy on outcome in aortic stenosis J Am Coll Cardiol 58 2011 570 576
24. R.B. D'Agostino Jr Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group Stat Med 17 1998 2265 2281 (Pubitemid 28466823)
25. R.B. D'Agostino Jr Propensity scores in cardiovascular research Circulation 115 2007 2340 2343 (Pubitemid 46685902)
26. R. Scognamiglio, S.H. Rahimtoola, G. Fasoli, S. Nistri, and S. Dalla Volta Nifedipine in asymptomatic patients with severe aortic regurgitation and normal left ventricular function N Engl J Med 331 1994 689 694 (Pubitemid 24275740)
27. M. Banaszewski, W. Rydlewska-Sadowska, and S. Rubkiewicz Captopril or nifedipine? Comparison of rest and exercise acute effects and long-term therapy in chronic isolated asymptomatic moderate to severe aortic regurgitation J Heart Valve Dis 7 1998 488 499 (Pubitemid 28435381)
28. F. Gisler, W. Knirsch, P. Harpes, and U. Bauersfeld Effectiveness of angiotensin-converting enzyme inhibitors in pediatric patients with mid to severe aortic valve regurgitation Pediatr Cardiol 29 2008 906 909
29. P.A. Grayburn Vasodilator therapy for chronic aortic and mitral regurgitation Am J Med Sci 320 2000 202 208
30. H.J. Levine, and W.H. Gaasch Vasoactive drugs in chronic regurgitant lesions of the mitral and aortic valves J Am Coll Cardiol 28 1996 1083 1091 (Pubitemid 26376978)
31. S. Yusuf, P. Sleight, J. Pogue, J. Bosch, R. Davies, G. Dagenais Heart Outcomes Prevention Evaluation Study Investigators Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients N Engl J Med 342 2000 145 153 (Pubitemid 30051645)
32. The SOLVD Investigators Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure N Engl J Med 325 1991 293 302
33. M.A. Pfeffer, E. Braunwald, and L.A. Moye Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction Results of the survival and ventricular enlargement trial N Engl J Med 327 1992 669 677 for the SAVE Investigators
34. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure Lancet 342 1993 821 828